Shanghai Pharma buys US Cardinal Health’s China business for $557 million

Deal gives the China business $1.2 billion enterprise value Shanghai Pharma keen to expand network nationwide Cardinal Health put business up for sale due to rule changes U.S. private-equity firm Warburg Pincus among bidders-sources Shanghai …
( read original story …)


Related Post